An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)

NCT00132730 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

604

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Diseases
Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: MK-0873 2.5 mg
DRUG: MK-0873 1.25 mg
DRUG: MK-0873 0.75 mg
DRUG: Placebo to MK-0873
DRUG: Usual Care

Sponsor

Merck Sharp & Dohme LLC